glp 1 black box warning The FDA sent a letter to the maker of Ozempic and Wegovy over unreported potential GLP-1 side effects. Here's what to know GLP-1 Medicines and Thyroid Cancer

Additionally, more patients saw significant weight loss in the combination group as compared to treatment with either phentermine or canagliflozin alone

If you or someone you care for is starting or currently taking a GLP-1 medication and has concerns about disordered eating, ask for support from a dietitian and mental health professional

Setting phone reminders and using a pill organizer with your weekly pen can prevent accidental skips

The Impact of Food Additives on the Abundance and Composition of Gut Microbiota

Are you still following your eating plan

The regulatory context for compounded GLP-1 in 2026 FDA removed semaglutide from its drug shortage list in early 2025, which changed the primary legal basis that had allowed widespread compounding of semaglutide under shortage-exemption rules